TREATMENT OF INOPERABLE LUNG-CARCINOMA - COMBINED MODALITY APPROACH

被引:13
作者
TAKITA, H
HOLLINSHEAD, AC
RIZZO, DJ
KRAMER, CM
CHEN, TY
BHAYANA, JN
EDGERTON, F
机构
[1] VET ADM HOSP,SURG SERV,BUFFALO,NY 14215
[2] GEORGE WASHINGTON UNIV,DEPT MED,WASHINGTON,DC 20006
关键词
D O I
10.1016/S0003-4975(10)63136-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Twenty-four patients with inoperable lung carcinoma other than of the small cell type who received cis diamminedichloro platinum (II)-based combination chemotherapy were further treated with all available treatment modalities: radiation therapy, lung resection, chemotherapy, and immunotherapy. There were 2 operative deaths, and 2 patients died 6 and 8 months postoperatively of cardiac causes. Postmortem examination on these 4 patients revealed no evidence of residual tumor. The remaining 20 patients are alive 7 to 33 months from the onset of chemotherapy and 4 to 27 months following lung resection. These results, although preliminary, are encouraging, and further study is in progress. © 1979, The Society of Thoracic Surgeons. All rights reserved.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 15 条
[1]  
BJORNSSON S, 1978, CANCER TREAT REP, V62, P505
[2]  
BRASHEAR RE, 1978, N AM REV RESPIR DIS, V117, P411
[3]   EVALUATION OF RISK IN PULMONARY RESECTION FOR BRONCHOGENIC CARCINOMA [J].
DIDOLKAR, MS ;
MOORE, RH ;
TAKITA, H .
AMERICAN JOURNAL OF SURGERY, 1974, 127 (06) :700-703
[4]  
FIDLER IJ, 1978, CANCER RES, V38, P2651
[5]   DELAYED-HYPERSENSITIVITY REACTIONS TO SOLUBLE MEMBRANE ANTIGENS OF HUMAN MALIGNANT LUNG-CELLS [J].
HOLLINSH.AC ;
STEWART, THM ;
HERBERMA.RB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (02) :327-338
[6]  
ROSWIT B, 1976, NEW YORK STATE J MED, V76, P560
[7]  
Selawry O S, 1974, Semin Oncol, V1, P259
[8]  
SHIELDS TW, 1972, CANCER, V30, P1388, DOI 10.1002/1097-0142(197211)30:5<1388::AID-CNCR2820300537>3.0.CO
[9]  
2-6
[10]  
SHIELDS TW, 1974, BRONCHIAL CARCINOMA, P92